Delivery Order SPE2DB22D2007-SPE2DB25FJ4MB
Award Date 8/29/25
Potential Completion Date 9/2/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,863.77 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This delivery order utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a $42,104.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on July 28, 2025, with completion targeted for July 29, 2025. This non-set-aside award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $1,003.39 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections with a completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections at a firm fixed price of $37,100.84, with completion required by August 1, 2025. This competitive award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The order will be fulfilled from the company's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors with a ceiling value of $2,287.74. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 26, 2025, and no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,097.54 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,416.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive, firm fixed-price delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,953.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections on August 28, 2025, with completion expected by August 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a $12,832.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen injections, with a completion date of August 29, 2025. This non-competitive delivery order represents a single pharmaceutical procurement through the federal medical supply chain and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...